v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (2,824,965) $ (2,951,268)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 1,098 608
Non-cash lease expense 28,025 31,867
Share-based compensation 121,208 63,599
Issuance of common stock to vendors for services 10,002 30,000
Change in operating assets and liabilities:    
Prepaid expenses and other current assets 457,210 605,534
Operating lease liability (27,484) (32,737)
Accounts payable and accrued expenses 322,307 691,290
Accrued compensation (445,124) (285,905)
Net cash flows from operating activities (2,357,723) (1,847,012)
Financing activities:    
Proceeds from issuance of common stock pursuant to At Market Issuance Sales Agreement 509,277 2,697,542
Costs associated with At Market Issuance Sales Agreement (58,277)  
Convertible debt repayments   (1,372,873)
Net cash flows from financing activities 451,000 1,324,669
Net decrease in cash and cash equivalents (1,906,723) (522,343)
Cash and cash equivalents at beginning of period 7,936,153 7,819,514
Cash and cash equivalents at end of period 6,029,430 7,297,171
Supplemental information:    
Cash paid for state income taxes 900 56,169
Cash paid for interest   35,044
Cash paid for lease liabilities:    
Operating lease 34,875 34,875
Non-cash investing and financing activities:    
Deferred issuance cost in accounts payable 39,639  
Deferred issuance cost reclassified to additional paid-in capital $ 17,742 $ 60,011